Amgen

Amgen Falls as Earnings, Revenue Disappoint
Barron's
Tue, 04/22/14 - 04:55 pm
Amgen
earnings
Earnings Preview: Amgen's timeline for Evolocumab will be in focus
The Fly on the Wall
Tue, 04/22/14 - 03:33 pm
earnings
Amgen
evolocumab
Pfizer, AstraZeneca Are Ripe for Pharma Deal Alone or Together
Yahoo/Bloomberg
Tue, 04/22/14 - 10:07 am
Pfizer
AstraZeneca
M&A
Bristol-Myers Squibb
Shire
Amgen
AbbVie
What to Watch for in Biotech Earnings This Week
Motley Fool
Tue, 04/22/14 - 09:33 am
biotech
earnings
Gilead Sciences
Celgene
Amgen
BiogenIdec
Today's Market: Other Potential Buyout Targets For Pfizer
Seeking Alpha
Mon, 04/21/14 - 11:25 am
M&A
Pfizer
AstraZeneca
Celgene
Biogen Idec
Amgen
FDA Grants Fast Track Status To Amgen Heart Failure Drug
Forbes
Fri, 04/18/14 - 08:51 am
FDA
Amgen
fast track
ivabradine
heart failure
Earnings Primer: What's on Deck for Amgen Inc. and Biogen Idec Inc.
Motley Fool
Thu, 04/17/14 - 11:19 am
Amgen
Biogen Idec
earnings
Top 10 Pharma M&A deals of 2013
Fierce Pharma
Thu, 04/17/14 - 08:29 am
M&A
Amgen
ONYX Pharmaceuticals
Bausch & Lomb
Valeant Pharmaceuticals
Elan
Perrigo
Actavis
Warner Chilcott
Bristol-Myers Squibb
AstraZeneca
Pearl Therapeutics
Agila
Mylan
Salix
Santarus
Bayer
Algeta
Shire
ViroPharma
[video]Amgen's Conundrum
Motley Fool
Mon, 04/14/14 - 06:18 pm
Amgen
Talimogene Laherparepvec
Are Celgene and Amgen Undervalued By the Market?
Motley Fool
Sat, 04/12/14 - 10:11 am
Amgen
Celgene
Amgen Spiking Lower 1.5%, Says Primary Endpoint of Durable Response Rate Met in Phase 3 Study of Talimogene, Secondary Endpoint Not Met
Yahoo/Benzinga
Fri, 04/4/14 - 09:14 am
Amgen
Talimogene Laherparepvec
melanoma
Amgen ends marketing agreement with GSK for osteoporosis drug
Yahoo/Reuters
Thu, 04/3/14 - 05:48 pm
Amgen
GSK
osteoporosis
Prolia
Xencor Inc.: Current Biotech Uncertainty Is An Opportunity
Seeking Alpha
Thu, 04/3/14 - 09:36 am
Xencor
Amgen
Roche
antibodies
Biogen Idec
Study: New Cholesterol Drugs Effectively Lower LDL Levels
Wall St Cheat Sheet
Tue, 04/1/14 - 08:16 am
cholesterol
Amgen
Sanofi
Regeneron
PCSK9 inhibitors
Amgen Drug Cuts Cholesterol Levels In Pivotal Studies
TheStreet.com
Mon, 03/31/14 - 10:18 am
Amgen
cholesterol
evolocumab
Amgen Drug Slashes Bad Cholesterol Within Weeks of Treatment
Bloomberg
Sun, 03/30/14 - 10:35 am
Amgen
cholesterol
evolocumab
New Cholesterol Fighters To Take Center Stage At ACC
Investors.com
Fri, 03/28/14 - 10:22 am
cholesterol
Pfizer
Amgen
Regeneron
Sanofi
PCSK9 inhibitors
American Cardiology Conference
alirocumab
Amgen - On Course To Change The Future
Seeking Alpha
Thu, 03/27/14 - 11:00 am
Amgen
Large Cap Biopharmaceuticals Are Core Holdings After Sell-Off: AbbVie, Amgen, Gilead
Seeking Alpha
Wed, 03/26/14 - 08:30 am
AbbVie
Amgen
Gilead Sciences
Achillion
Alexion
Ariad Pharmaceuticals
Pharmacyclics
Seattle Genetics
JPMorgan Sees No Bubble, Hears No Bubble as Biotech Falls Again
Barron's
Mon, 03/24/14 - 11:29 am
biotech
Biogen Idec
Amgen
Celgene
Gilead Sciences
Regeneron

Pages